--:--:--ET

live

S&P 5007,386.65

NASDAQ29,084.5

DOW50,872.11+2.56%

VIX20.95+16.00%

US10Y4.53+1.21%

EUR/USD1.1534-0.01%

GOLD4,064.2-4.50%

WTI4.28+11.46%

BTC61,438.75

S&P 5007,386.65

NASDAQ29,084.5

DOW50,872.11+2.56%

VIX20.95+16.00%

US10Y4.53+1.21%

EUR/USD1.1534-0.01%

GOLD4,064.2-4.50%

WTI4.28+11.46%

BTC61,438.75

4503.T

Astellas Pharma Inc.

HealthcareDrug Manufacturers - GeneralJPJPYPeers →Country macro →

$2,140.50

Jun 10, 2026

Market cap

$3.72T

52w range

—

P / E

—

EPS · FY 2026

$162.22

Volume

—

Revenue · FY 2026

$2.14T

Overview Profile Financials Ratios Multiples Valuation Factors Quant Themes Trend Thesis Committee Earnings Segments Prices Analysts Dividends Corp actions Sentiment ESG

Explain this page

Arphra AIPlain-English read on Astellas Pharma Inc.’s valuation

No corporate actions

No dividend or split records loaded for 4503-JT.